MedTrace Logo

Mother-to-child Hepatitis D Transmission

NCT02044055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54

Last updated 2017-04-27

No results posted yet for this study

Summary

HBV can be transmitted from mother-to-child, with a risk increasing according to maternal HBV DNA during pregnancy. HDV is a defective virus using HBs Ag for its own replication. Nucleosides analogues have only a minor impact on quantitative HBs Ag level. Data about vertical HDV transmission are old, justifying a new study.

Conditions

  • Hepatitis D
  • Transmission

Sponsors & Collaborators

  • Hopital Lariboisière

    lead OTHER

Principal Investigators

  • Pierre O SELLIER, M.D., Ph.D · Hopital Lariboisiere

Eligibility

Min Age
9 Months
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02044055 on ClinicalTrials.gov